Zoletil 100 (50 mg/ml+50 mg/ml) Lyophilisate and Solvent for Solution for Injection for Dogs and Cats

Ország: Egyesült Királyság

Nyelv: angol

Forrás: VMD (Veterinary Medicines Directorate)

Vedd Meg Most

Termékjellemzők Termékjellemzők (SPC)
21-09-2023

Aktív összetevők:

Tiletamine, Zolazepam

Beszerezhető a:

Virbac

ATC-kód:

QN01AX99

INN (nemzetközi neve):

Tiletamine, Zolazepam

Gyógyszerészeti forma:

Lyophilisate and solvent for solution for injection

Recept típusa:

POM-V - Prescription Only Medicine – Veterinarian

Terápiás csoport:

Cats, Dogs

Terápiás terület:

Neurological Agent general anaesthetic

Engedélyezési státusz:

Authorized

Engedély dátuma:

2016-04-20

Termékjellemzők

                                Revised: April 2023
AN: 00777/2022 & 00782/2022
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
ZOLETIL 100 (50 mg/ml+50 mg/ml) Lyophilisate and Solvent for Solution
for Injection
for Dogs and Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial of 970 mg lyophilisate contains:
Active substances:
Tiletamine (as hydrochloride)
250.00 mg
Zolazepam (as hydrochloride)
250.00 mg
Each vial of 5 ml solvent contains:
Benzyl alcohol (E1519)
0.100 g
Water for injections
5.00 ml
Each ml of reconstituted solution contains:
Active substances:
Tiletamine (as hydrochloride)
50.00 mg
Zolazepam (as hydrochloride)
50.00 mg
Excipient:
Benzyl alcohol (E1519)
20.00 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
Appearance of the lyophilisate: White to slightly yellow compact mass;
Appearance of the solvent: Clear colourless liquid;
Appearance of the reconstituted solution: Clear, colourless to
slightly green-yellow
solution, free from particles.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
General anaesthesia.
Revised: April 2023
AN: 00777/2022 & 00782/2022
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
Do not use in animals with severe cardiac or respiratory disease, or
in animals with
renal, pancreatic or hepatic insufficiency.
Do not use in the event of severe hypertension.
Do not use in rabbits.
Do not use in animals with head trauma or intracranial tumours.
Do not use for caesarean section.
Do not use in pregnant bitches and queens.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In dogs, since zolazepam is eliminated more quickly than tiletamine,
there is a shorter
duration of tranquilisation than there is of anaesthesia.
4.5
SPECIAL PRECAUTIONS FOR USE
i) Special precautions for use in animals
Animals should be fasted for 12 hours prior to anaesthesia.
Re
                                
                                Olvassa el a teljes dokumentumot
                                
                            

A termékkel kapcsolatos riasztások keresése